<DOC>
<DOCNO>
EP-0015370
</DOCNO>
<TEXT>
<DATE>
19800917
</DATE>
<IPC-CLASSIFICATIONS>
C07F-9/00 <main>C07F-9/38</main> C07F-9/38 A61K-31/66 C07F-9/40 
</IPC-CLASSIFICATIONS>
<TITLE>
diphosphonate or phosphate-phosphonate derivatives and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
symphar sach<sep>symphar s.a.<sep>symphar s.a.243, route des fayardsch-1290 versoixch<sep>symphar s.a. <sep>
</APPLICANT>
<INVENTOR>
bentzen craig l<sep>nguyen mong lan<sep>niesor eric<sep>bentzen, craig l.<sep>nguyen mong, lan<sep>niesor, eric<sep>bentzen, craig l.18, rue des bossonsch-1213 onex genèvech<sep>nguyen mong, lan7, chemin du pré-fleurich-1260 nyon vaudch<sep>niesor, eric12, rue du midich-1196 gland vaudch<sep>bentzen, craig l.<sep>nguyen mong, lan  <sep>niesor, eric<sep>bentzen, craig l.18, rue des bossonsch-1213 onex genèvech<sep>nguyen mong, lan7, chemin du pré-fleurich-1260 nyon vaudch<sep>niesor, eric12, rue du midich-1196 gland vaudch<sep>
</INVENTOR>
<ABSTRACT>
this invention relates to new diphosphonate com­ pounds of formula (i)    where x is h, oh,   o--ch₃ or nh₂; r and r′ identical or  different are h, ch₃ or c₂h₅; m is zero or 1; and a is se­ lected from the group comprising (ch₃)₃c-, y-c₆h₄-,  y-c₆h₄-o-c(ch₃)₂-, y-c₆h₄-c(ch₃)₂-, y-c₆h₄-o-c₆h₄-,  y-c₆h₄-(ch₂)n- and y-c₆h₄-o-(ch₂)n-, where n ist an in­ teger from 1 to 6 and y is h, ch₃, och₃ or cl.  these com­ pounds posses remarkable activity as hypoglycemic and/or  antiatherogenic agents, and are usable in pharmaceutical  compositions to alter lipoprotein profiles in favour of high  density lipoproteins and to clear cholesterol from various  tissues.  
</ABSTRACT>
</TEXT>
</DOC>
